SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Martens Ulf) "

Search: WFRF:(Martens Ulf)

  • Result 1-10 of 17
Sort/group result
   
EnumerationReferenceCoverFind
1.
  • Barausse, Enrico, et al. (author)
  • Prospects for fundamental physics with LISA
  • 2020
  • In: General Relativity and Gravitation. - : SPRINGER/PLENUM PUBLISHERS. - 0001-7701 .- 1572-9532. ; 52:8
  • Journal article (other academic/artistic)abstract
    • In this paper, which is of programmatic rather than quantitative nature, we aim to further delineate and sharpen the future potential of the LISA mission in the area of fundamental physics. Given the very broad range of topics that might be relevant to LISA,we present here a sample of what we view as particularly promising fundamental physics directions. We organize these directions through a "science-first" approach that allows us to classify how LISA data can inform theoretical physics in a variety of areas. For each of these theoretical physics classes, we identify the sources that are currently expected to provide the principal contribution to our knowledge, and the areas that need further development. The classification presented here should not be thought of as cast in stone, but rather as a fluid framework that is amenable to change with the flow of new insights in theoretical physics.
  •  
2.
  •  
3.
  • Bonagas, Nadilly, et al. (author)
  • Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress
  • 2022
  • In: NATURE CANCER. - : Springer Science and Business Media LLC. - 2662-1347. ; 3:2, s. 156-
  • Journal article (peer-reviewed)abstract
    • The folate metabolism enzyme MTHFD2 (methylenetetrahydrofolate dehydrogenase/cyclohydrolase) is consistently overexpressed in cancer but its roles are not fully characterized, and current candidate inhibitors have limited potency for clinical development. In the present study, we demonstrate a role for MTHFD2 in DNA replication and genomic stability in cancer cells, and perform a drug screen to identify potent and selective nanomolar MTHFD2 inhibitors; protein cocrystal structures demonstrated binding to the active site of MTHFD2 and target engagement. MTHFD2 inhibitors reduced replication fork speed and induced replication stress followed by S-phase arrest and apoptosis of acute myeloid leukemia cells in vitro and in vivo, with a therapeutic window spanning four orders of magnitude compared with nontumorigenic cells. Mechanistically, MTHFD2 inhibitors prevented thymidine production leading to misincorporation of uracil into DNA and replication stress. Overall, these results demonstrate a functional link between MTHFD2-dependent cancer metabolism and replication stress that can be exploited therapeutically with this new class of inhibitors. Helleday and colleagues describe a nanomolar MTHFD2 inhibitor that causes replication stress and DNA damage accumulation in cancer cells via thymidine depletion, demonstrating a potential therapeutic strategy in AML tumors in vivo.
  •  
4.
  • Carreras-Puigvert, Jordi, et al. (author)
  • A comprehensive structural, biochemical and biological profiling of the human NUDIX hydrolase family
  • 2017
  • In: Nature Communications. - : Nature Publishing Group. - 2041-1723. ; 8:1
  • Journal article (peer-reviewed)abstract
    • The NUDIX enzymes are involved in cellular metabolism and homeostasis, as well as mRNA processing. Although highly conserved throughout all organisms, their biological roles and biochemical redundancies remain largely unclear. To address this, we globally resolve their individual properties and inter-relationships. We purify 18 of the human NUDIX proteins and screen 52 substrates, providing a substrate redundancy map. Using crystal structures, we generate sequence alignment analyses revealing four major structural classes. To a certain extent, their substrate preference redundancies correlate with structural classes, thus linking structure and activity relationships. To elucidate interdependence among the NUDIX hydrolases, we pairwise deplete them generating an epistatic interaction map, evaluate cell cycle perturbations upon knockdown in normal and cancer cells, and analyse their protein and mRNA expression in normal and cancer tissues. Using a novel FUSION algorithm, we integrate all data creating a comprehensive NUDIX enzyme profile map, which will prove fundamental to understanding their biological functionality.
  •  
5.
  • Gad, Helge, et al. (author)
  • MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool
  • 2014
  • In: Nature. - : Nature Publishing Group. - 0028-0836 .- 1476-4687. ; 508:7495, s. 215-221
  • Journal article (peer-reviewed)abstract
    • Cancers have dysfunctional redox regulation resulting in reactive oxygen species production, damaging both DNA and free dNTPs. The MTH1 protein sanitizes oxidized dNTP pools to prevent incorporation of damaged bases during DNA replication. Although MTH1 is non-essential in normal cells, we show that cancer cells require MTH1 activity to avoid incorporation of oxidized dNTPs, resulting in DNA damage and cell death. We validate MTH1 as an anticancer target in vivo and describe small molecules TH287 and TH588 as first-in-class nudix hydrolase family inhibitors that potently and selectively engage and inhibit the MTH1 protein in cells. Protein co-crystal structures demonstrate that the inhibitors bindin the active site of MTH1. The inhibitors cause incorporation of oxidized dNTPs in cancer cells, leading to DNA damage, cytotoxicity and therapeutic responses in patient-derived mouse xenografts. This study exemplifies the non-oncogene addiction concept for anticancer treatment and validates MTH1 as being cancer phenotypic lethal.
  •  
6.
  • Johansson, Henrik J., et al. (author)
  • Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer
  • 2013
  • In: Nature Communications. - : Nature Publishing Group: Nature Communications. - 2041-1723. ; 4:3175
  • Journal article (peer-reviewed)abstract
    • About one-third of oestrogen receptor alpha-positive breast cancer patients treated with tamoxifen relapse. Here we identify the nuclear receptor retinoic acid receptor alpha as a marker of tamoxifen resistance. Using quantitative mass spectrometry-based proteomics, we show that retinoic acid receptor alpha protein networks and levels differ in a tamoxifen-sensitive (MCF7) and a tamoxifen-resistant (LCC2) cell line. High intratumoural retinoic acid receptor alpha protein levels also correlate with reduced relapse-free survival in oestrogen receptor alpha-positive breast cancer patients treated with adjuvant tamoxifen solely. A similar retinoic acid receptor alpha expression pattern is seen in a comparable independent patient cohort. An oestrogen receptor alpha and retinoic acid receptor alpha ligand screening reveals that tamoxifen-resistant LCC2 cells have increased sensitivity to retinoic acid receptor alpha ligands and are less sensitive to oestrogen receptor alpha ligands compared with MCF7 cells. Our data indicate that retinoic acid receptor alpha may be a novel therapeutic target and a predictive factor for oestrogen receptor alpha-positive breast cancer patients treated with adjuvant tamoxifen.
  •  
7.
  •  
8.
  • Johansson, Patrik, et al. (author)
  • A Patient-Derived Cell Atlas Informs Precision Targeting of Glioblastoma
  • 2020
  • In: Cell Reports. - : Elsevier BV. - 2211-1247. ; 32:2
  • Journal article (peer-reviewed)abstract
    • Glioblastoma (GBM) is a malignant brain tumor with few therapeutic options. The disease presents with a complex spectrum of genomic aberrations, but the pharmacological consequences of these aberrations are partly unknown. Here, we report an integrated pharmacogenomic analysis of 100 patient-derived GBM cell cultures from the human glioma cell culture (HGCC) cohort. Exploring 1,544 drugs, we find that GBM has two main pharmacological subgroups, marked by differential response to proteasome inhibitors and mutually exclusive aberrations in TP53 and CDKN2A/B. We confirm this trend in cell and in xenotransplantation models, and identify both Bcl-2 family inhibitors and p53 activators as potentiators of proteasome inhibitors in GBM cells, We can further predict the responses of individual cell cultures to several existing drug classes, presenting opportunities for drug repurposing and design of stratified trials. Our functionally profiled biobank provides a valuable resource for the discovery of new treatments for GBM.
  •  
9.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-10 of 17
Type of publication
journal article (14)
other publication (3)
Type of content
peer-reviewed (12)
other academic/artistic (5)
Author/Editor
Martens, Ulf (15)
Lundgren, Bo (14)
Häggblad, Maria (13)
Nelander, Sven (7)
Johansson, Patrik (6)
Helleday, Thomas (5)
show more...
Loseva, Olga (5)
Kundu, Soumi (5)
Baskaran, Sathishkum ... (5)
Scobie, Martin (5)
Jemth, Ann-Sofie (5)
Schmidt, Linnea (5)
Elfineh, Lioudmila (4)
Krona, Cecilia (4)
Llona-Minguez, Sabin (4)
Jenmalm Jensen, Anni ... (3)
Lundbäck, Thomas (3)
Almstedt, Elin (3)
Stenmark, Pål (3)
Uhrbom, Lene (3)
Wiita, Elisee (3)
Johansson, Lars (2)
Henriksson, Martin (2)
Krona, Cecilia, 1976 (2)
Gallant, Caroline (2)
Westermark, Bengt (2)
Artursson, Per (2)
Svensson, Richard (2)
Gallant, Caroline J. (2)
Jörnsten, Rebecka (2)
Elgendy, Ramy (2)
Doroszko, Milena (2)
Forsberg-Nilsson, Ka ... (2)
Baskaran, Sathishkum ... (2)
Lane, David P. (2)
Baranczewski, Pawel (2)
Berntsson, Ronnie P. ... (2)
Pham, Therese (2)
Höglund, Andreas (2)
Vallin, Karl S. A. (2)
Sanjiv, Kumar (2)
Desroses, Matthieu (2)
Kalderen, Christina (2)
Koolmeister, Tobias (2)
Homan, Evert J. (2)
Vinel, Claire (2)
Marino, Silvia (2)
Carreras-Puigvert, J ... (2)
Warpman Berglund, Ul ... (2)
Matuszewski, Damian ... (2)
show less...
University
Uppsala University (12)
Stockholm University (11)
Karolinska Institutet (9)
University of Gothenburg (5)
Royal Institute of Technology (2)
Linköping University (2)
show more...
Lund University (1)
Chalmers University of Technology (1)
Swedish Museum of Natural History (1)
Swedish University of Agricultural Sciences (1)
show less...
Language
English (17)
Research subject (UKÄ/SCB)
Medical and Health Sciences (14)
Natural sciences (11)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view